|
|
 |
|
|
| Lubiprostone |
| Lubiprostone is a drug used in the management of idiopathic chronic constipation. It was approved by the U.S. Food and Drug Administration for this purpose on January 31, 2006. Manus Aktteva offers Lubiprostone, 136790-76-6, for RND quantities, along with its intermediates for evaluation, pilots and commercial requirements with supportive technical package required for evaluation for intermediates. |
| Product Reference ID: MA-GA-551-O |
|
|
| Chemical Name: |
7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy- 8-oxo-2-oxabicyclo[4.3.0]non-7-yl]heptanoic acid |
|
|
| Description |
| CAS number |
136790-76-6 |
| Synonym |
7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy- 8-oxo-2-oxabicyclo[4.3.0]non-7-yl]heptanoic acid, Lubiprostone |
| Molecular Formula |
C20H32F2O5 |
| Molecular Weight |
390.46 |
| Specifications |
Detailed Specification and Certificate of Analysis available on request |
| Packing |
Export worthy packing |
| Application |
A gastrointestinal agent used for the treatment of idiopathic chronic constipation. |
Material Safety Data Sheet
|
Available on request
|
| Availability |
RND quantities available promptly |
| Comments |
NMR, HNMR, Method Of Analysis available with shipment. |
|
|
|
|
|
|
 Are you looking for Lubiprostone Intermediates ? Please click here to browse through the list of Lubiprostone Intermediates available with us. |
|
|
|
|
|
|
 |
NOTE: 
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|